Free Trial

Ultragenyx Pharmaceutical (RARE) SEC Filings & 10K Form

Ultragenyx Pharmaceutical logo
$26.31 -1.10 (-4.01%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$26.20 -0.11 (-0.42%)
As of 07/18/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Ultragenyx Pharmaceutical SEC Filings

DateFilerForm TypeView
07/11/2025
3:46 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2025
3:30 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2025
7:15 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
12:50 PM
Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:31 PM
Ray Amrit (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:31 PM
Dunsire Deborah (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:32 PM
Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:32 PM
NARACHI MICHAEL (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:33 PM
Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:33 PM
Ultragenyx Pharmaceutical (Issuer)
WELCH DANIEL G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:34 PM
SULIMAN SHEHNAAZ (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
6:18 PM
Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
8:12 AM
BlackRock, Inc. (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SCHEDULE 13G/A
03/28/2025
4:00 PM
Ultragenyx Pharmaceutical (Filer)
Form DEF 14A
03/28/2025
4:01 PM
Ultragenyx Pharmaceutical (Filer)
Form DEFA14A
03/28/2025
4:02 PM
Ultragenyx Pharmaceutical (Filer)
Form ARS
03/10/2025
11:53 AM
Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:16 PM
Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:18 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:19 PM
Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:56 PM
Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:02 PM
Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:06 PM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:10 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:12 PM
Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
12:58 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:58 PM
Ultragenyx Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
10:42 AM
SANDS CAPITAL MANAGEMENT, LLC (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SCHEDULE 13G/A
02/10/2025
9:25 AM
Ultragenyx Pharmaceutical (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
01/13/2025
7:30 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
1:05 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:32 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2024
3:17 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
7:30 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
5:44 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
5:47 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:12 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
5:42 AM
RTW INVESTMENTS, LP (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SC 13G/A
11/05/2024
3:06 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:48 PM
Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Is Elon's empire crumbling? (Ad)

The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Click here to see the Tesla shock that could blindside everyone.
10/07/2024
7:15 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:34 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
12:03 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
10:50 AM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
10:53 AM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:40 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
1:48 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:28 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RARE) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners